Risk Stratification Cohorting
NHS England · awarded 31 March 2023
Who
| Buyer | NHS England Leeds |
|---|---|
| Supplier |
CGI IT UK Limited |
| Category | services |
| Classification | Software maintenance and repair services CPV 72267000 |
| Notice published | 18 May 2026 |
What it is for
The NHSE Cohorting (formerly known as Risk Stratification) programme has created tools which will help clinicians and the public to understand an individuals' risk of Covid-19 as well as deploying recently approved therapeutic treatments. Using functionality and infrastructure developed for Covid-19 the Cohorting delivery team within the NHSE Platforms Directorate are also developing a 'Cohorting as a service' function which will underpin strategic initiatives such as Covid Vaccination and Screening Therapeutics. This service will deliver consistent, clinically assured, timely and cost efficient cohorting for the NHS, whilst also helping to lay the groundwork for the delivery of future goals of the NHS such as personalised healthcare and preventative medicine. The Initial Contract Value is £25,600,000 (£32,000,000 including the optional extension period). VARIATION The value of this variation is £12,800,000. This variation is being made in accordance with Regulation 72(1)(b) of the Public Contract Regulations 2015. The scope of services provided under the contract remain the same, with the variation facilitating a continuation of support while a re-procurement and transition to a new agreement continues. The Total Contract Value is £44,800,000.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
1269 awards on file, worth £50.2bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 4 Mar 2026 | New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland | NHS England | Willmott Dixon Construction Limited +9 | £37.0bn |
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
Everything NHS England has awarded →
Other contracts won by this supplier
69 awards on file, worth £1.7bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 26 Jan 2024 | Consultancy and Advisory Services for Health | N H S Shared Business Services | Drees & Sommer UK Limited +162 | £500.0m |
| 10 Oct 2025 | EIS and CDIO B&T Lot 1 | H M REVENUE & CUSTOMS | CGI IT UK LIMITED | £240.0m |
| 20 Oct 2025 | Technology Transformation & Delivery Framework Contract Award - TECH-178 | BANK OF ENGLAND | ACCENTURE (UK) LIMITED +15 | £180.0m |
| 13 Nov 2025 | Application Services Contract - Modernisation Priority | Ministry of Justice | CGI IT UK Ltd | £101.0m |
| 21 Aug 2025 | BLC0206 - Robotic Process Automation (RPA) Framework - AWARD | BlueLight Commercial | Accenture +11 | £76.0m |